Table 1: Patient characteristics.
Characteristic |
Entire cohort (N = 108) |
Age (median, SD) |
60.12 (13.69) |
Gender, n (%) |
|
Male |
45 (41.7) |
Female |
63 (58.3) |
Localización del tumor, n (%) |
|
Cabeza y cuello |
11 (10.2) |
Linfoma |
24 (22.2) |
Mama |
23 (21.3) |
Colorectal |
7 (6.5) |
Ginecológico |
9 (8.3) |
Pulmón |
15 (13.9) |
Esofagogastrico |
6 (5.6) |
Sarcoma partes blandas |
2 (1.9) |
Melanoma |
4 (3.7) |
TNE |
3 (2.8) |
Otros |
4 (3.7) |
Tratamiento, n (%) |
|
No tratamiento |
29 (26.9) |
Cirugía |
14 (13) |
QT |
22 (20.4) |
CX + QT |
13 (12) |
QT + RT |
12 (11.1) |
CX + RT |
3 (2.8) |
Todo |
15 (13.9) |
PET/CT Indication, n (%) |
|
Initial staging |
33 (30.6) |
Monitoring treatment |
48 (44.4) |
Relapse |
27 (25) |
PET previos, n (%) |
|
No (1a vez) |
57 (52.8) |
Si (más veces) |
51 (47.2) |
Número de PET previos (median, SD) |
1.03 (1.5) |